Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study to Investigate the Safety and Preliminary Efficacy of GX-I7 in Patients With COVID-19

NCT04730427 is registered in ClinicalTrials.gov with Genexine, Inc. as lead sponsor.

NCT NCT04730427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04730427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study to Investigate the Safety and Preliminary Efficacy of GX-I7 in Patients With COVID-19
Lead sponsor
Genexine, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
March 24, 2021
Completion date
July 7, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19